ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > LRP-5

LRP-5

概要

Name:Low-density lipoprotein receptor-related protein 5
Target Synonym:
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
LR5-H82E6 Human Biotinylated Human LRP-5 Protein, His,Avitag™
LR5-H82E6-structure
LR5-H82E6-sds
LR5-H5254 Human Human LRP-5 Protein, Mouse IgG2a Fc Tag
LR5-H5254-structure
LR5-H5254-sds
ACRO Quality

生物活性データの一部

LR5-H5254-ELISA
 LRP-5 ELISA

Immobilized Biotinylated Human Dkk-1, Fc,Avitag (Cat. No. DK1-H82F5) at 5 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Human LRP-5, Mouse IgG2a Fc Tag (Cat. No. LR5-H5254) with a linear range of 1-31 ng/mL (QC tested).

Synonym Name

LRP5,LRP-5,LRP-7,LRP7,LR3

Background

Low-density lipoprotein receptor-related protein 5(LRP-5) is also known as  BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPTA1, VBCH2, LDL receptor related protein 5 and PCLD4. LRP5 is a transmembrane low-density lipoprotein receptor that shares a similar structure with LRP6. LRP5 acts as a co-receptor with LRP6 and the Frizzled protein family members for transducing signals by Wnt proteins through the canonical Wnt pathway. This protein plays a key role in skeletal homeostasis. Mutations in LRP5 can lead to considerable changes in bone mass. A loss-of-function mutation causes osteoporosis-pseudoglioma (decrease in bone mass), while a gain-of-function mutation causes drastic increases in bone mass.

Clinical and Translational Updates

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
BI-905681 BI-905681 Phase 1 Clinical Boehringer Ingelheim Ltd Neoplasms Details

This web search service is supported by Google Inc.

totopphone